Standout Papers

Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis 2020 2026 2022 2024192
  1. Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis (2020)
    James D. Chalmers, Charles Haworth et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 2 from Science/Nature 51 standout
Sub-graph 1 of 24

Citing Papers

Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
2025 Standout
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
1 intermediate paper

Works of Eugene J. Sullivan being referenced

Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
2020 Standout

Author Peers

Author Last Decade Papers Cites
Eugene J. Sullivan 615 478 99 153 25 958
Michael C. Nivens 351 395 101 122 24 854
Katerina Samara 773 336 47 49 28 1.0k
B G McCann 331 187 176 139 24 741
Ruth Sepper 424 231 152 46 28 1.0k
Marilyn H. Duncan 151 592 185 326 17 1.0k
Danielle Antin‐Ozerkis 630 181 147 57 23 1.2k
Susan S. Jacobs 415 318 99 69 18 748
Yale Jiang 435 153 112 87 36 1.0k
Minoru Inomata 593 147 159 63 62 904
Richard Shames 171 338 44 75 19 881

All Works

Loading papers...

Rankless by CCL
2026